L&T Technology Services Launches Second Annual Digital Engineering Awards, in collaboration with ISG and CNBC TV-18
15.9.2023 11:30:00 EEST | Business Wire | Press release
L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a leading global digital engineering and R&D company, today announced the launch of the second-annual Digital Engineering Awards, in association with Information Services Group (ISG), a leading global technology research and advisory firm, and business news channel CNBC TV-18 in India.
The Digital Engineering Awards recognize and celebrate business and technology trailblazers who are crafting a smarter and more sustainable world through transformative ideas that leverage digital engineering.
Enterprises and their service providers are invited to submit nominations through October 5, with winners announced during a gala awards celebration on December 6 in Dallas, Tex., U.S.A. Enterprise award winners, selected by a global panel of industry experts, including representatives of ISG, will be named in nine categories – five team awards and four individual awards:
Engineering the Change Team Awards
- Digital Transformation of the Year
- Top Sustainability Initiative
- Digital Engineering Program of the Year
- Engineering Product of the Year
- Value Realization
Engineering at Heart Individual Awards
- Distinguished Digital Engineer
- Digital Engineer of the Year
- Woman Engineer of the Year
- Innovator of the Year
The inaugural Digital Engineering Awards gala was held last year in Jersey City, N.J., United States, with 120 nominees, including over 70 industry-leading global enterprises, in attendance. Winners, both individual engineers and teams, included representatives from Airbus, American Honda Motor Co., Inc./ Honda Marine, Chevron, ExxonMobil, GE Healthcare, Intel Corporation, Microsoft, Rolls-Royce, and Qualcomm Technologies.
Remarking on the occasion, Mr. Amit Chadha, CEO and Managing Director at L&T Technology Services said, "We take immense pride in having witnessed the tremendous success of the maiden Digital Engineering Awards, which celebrated disruptive innovations across a broad spectrum of deep technologies, spanning automotive, aerospace, industrial products, telecom, plant engineering, and medical devices. As we persist in our unwavering commitment to engineering research and development, aiming to shape a future enabled by engineering marvels, we are eager to extend our endeavors in spotlighting extraordinary innovation and leadership that spearheads transformation towards a sustainable, digitally empowered tomorrow."
“Digital engineering is the fabric that connects all facets of the digital world and makes future innovations possible,” said Michael P. Connors, Chairman and CEO of ISG. “Following the great success of the inaugural Digital Engineering Awards, we are delighted once again to collaborate with L&T Technology Services and CNBC-TV18 to recognize the outstanding work of individuals and teams whose groundbreaking innovations will shape the digital landscape for years to come.”
“The Digital Engineering Awards have a key role to play in celebrating the new-age digital solutions that are driving immense growth in the ER&D sector. Our role as media partner with L&T Technology Services aligns perfectly with the long-standing objective of our brands – CNBC-TV18 and Moneycontrol – to educate audiences about innovations and developments in the worlds of technology and business,” said S. Shivakumar: President, News18 Studios.
About the Digital Engineering Awards
The Digital Engineering Awards bring together industry leaders to recognize outstanding achievements in the R&D domain, and to help global organizations give shape to their transformative ideas. The Awards are produced by L&T Technology Services in association with ISG, with CNBC TV18 as a media partner. For more about the Awards, visit this website (www.digitalengineeringawards.com) or contact us at info@digitalengineeringawards.com
About Network18
Network18 Media & Investments Limited is a major Indian media conglomerate owned by Reliance Industries. The company operates a wide array of channels spanning news, entertainment, and digital content. Its portfolio includes CNBC-TV18, CNBC-AWAAZ, CNBC-Bajar, CNN-NEWS18, News18 India, and News18 regional news channels across languages and markets.
About ISG
ISG (Information Services Group) is a leading global technology research and advisory firm. A trusted business partner to more than 900 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,600 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.
About L&T Technology Services Ltd
L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 57 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 23,300 employees spread across 22 global design centers, 28 global sales offices and 102 innovation labs as of June 30, 2023. For more information, please visit https://www.LTTS.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230914274834/en/
Contact information
Aniruddha Basu
L&T Technology Services Limited
E: Aniruddha.Basu@Ltts.com
Anindita Sarkar
L&T Technology Services Limited
E: Anindita.Sarkar@Ltts.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release
The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 12:00:00 EEST | Press release
The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that elevates high-performance riders and horses to their rightful place on the world stage. Built on merit, integrity, and excellence, the PJL brings together the world’s best athletes to compete for the biggest prize pot in the discipline’s history, helping to create a more resilient, long-term financial model for the sport. Represented by sixteen teams, the PJL will introduce an industry-first rider selection process from a pool of 250 of the world’s leading riders. World-class, immersive events will unfold across fourteen ic
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 12:00:00 EEST | Press release
Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkbj) for the treatment of spastic cerebral palsy (CP). On top of safety and tolerability, the study will evaluate improvements in daily functioning, quality of life, motor abilities, and neurodevelopmental measures of the Cenegermin-bkbj intranasal formulation. CP is the most common motor disability in childhood, caused by injury or changes during early brain development. The most prevalent form, spastic CP, leads to muscle stiffness and difficulty with movement.2 “Cerebral palsy is a devastating disease, and for patients and families there are still no proven treatments beyond supportive care,” said Marcello Allegretti, Chief Scientific Officer at Dompé. “With our emerging intranasal NGF p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom